Models

Dataset Information

0

Eftimie2019-Macrophages Plasticity


ABSTRACT: This paper describes the complex interactions between two extreme types of macrophages (M1 and M2 cells), effector T cells and an oncolytic Vesicular Stomatitis Virus (VSV), on the growth/elimination of B16F10 melanoma. The mathematics model descirbes, in terms of VSV and macrophages levels, two different types of immune responses which could ensure tumour control and eventual elimination. It shows that both innate and adaptive anti-tumour immune responses, as well as the oncolytic virus, could be very important in delaying tumour relapse and eventually eliminating the tumour. Overall this study supports the use mathematical modelling to increase our understanding of the complex immune interaction following oncolytic virotherapies. However, the complexity of the model combined with a lack of sufficient data for model parametrisation has an impact on the possibility of making quantitative predictions. The Model was created using COPASI version 4.24 (Build 197)

DISEASE(S): Skin Cancer,Cancer

SUBMITTER: Szeyi Ng  

PROVIDER: BIOMD0000000806 | BioModels | 2019-10-03

REPOSITORIES: BioModels

altmetric image

Publications

Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies.

Eftimie R R   Eftimie G G  

Acta biotheoretica 20190813 4


Over the last few years, oncolytic virus therapy has been recognised as a promising approach in cancer treatment, due to the potential of these viruses to induce systemic anti-tumour immunity and selectively killing tumour cells. However, the effectiveness of these viruses depends significantly on their interactions with the host immune responses, both innate (e.g., macrophages, which accumulate in high numbers inside solid tumours) and adaptive (e.g., [Formula: see text] T cells). In this artic  ...[more]

Similar Datasets

2018-01-01 | S-EPMC6008949 | BioStudies
2019-07-31 | BIOMD0000000769 | BioModels
2019-07-31 | BIOMD0000000770 | BioModels
1000-01-01 | S-EPMC4681611 | BioStudies
2017-01-01 | S-EPMC5423491 | BioStudies
2019-01-01 | S-EPMC6889376 | BioStudies
2016-01-01 | S-EPMC4728569 | BioStudies
2016-01-01 | S-EPMC5086626 | BioStudies
1000-01-01 | S-EPMC6224581 | BioStudies
2017-01-01 | S-EPMC5337983 | BioStudies